Home » Topics » BioWorld Science

BioWorld Science
RSS

EMA committee hands down negative opinion for masitinib in ALS

April 20, 2018

Novel genetically altered broadly neutralizing antibodies protect monkeys from SHIV

April 20, 2018

FDA advisory committee recommends approval of Epidiolex for LGS and Dravet syndrome

April 20, 2018

Johnson & Johnson reviews progress of first quarter 2018

April 20, 2018

ADC Therapeutics presents potent antitumoral compounds in xenograft models

April 20, 2018

FDA accepts Veloxis' sNDA for Envarsus XR

April 20, 2018

First-in-human study of FS-118 in advanced solid tumors enrolling subjects

April 20, 2018

Otsuka launches Rexulti in Japan

April 20, 2018

Goofice tablet launched in Japan

April 20, 2018

CD163, VCAM-1 identified as markers of liver injury in autoimmune hepatitis

April 20, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...